Loading company…
ZymoBiotech provides synthetic biology and gene editing technologies for biofuels and biomaterials.
Founded in 2021, ZymoBiotech provides gene editing and synthetic biology services for energy and materials manufacturers. Its ZymOmics platform supports analysis and strain development, including production of compounds from agricultural straw and waste starch. The company is based in Wuhan, China. In May 2026, it raised Series B funding.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in